ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

AN ASSESSMENT OF THE CLINICAL IMPACT AND PROFILE OF REGULAR MANAGEMENT IN CASE OF ACUTE POISONING OF ORGANOPHOSPHORUS PESTICIDE

AUTHORS:

Dr. Aneela Naz, Dr Muhammad Almas Murad, Dr Asma Ashiq

ABSTRACT:

Background: All around the globe, the frequently occurring form of poisoning is acute poisoning with organophosphorus (OP) pesticides. By chance or by choice inhalation, ingestion or cutaneous exposure are most likely the cause of this poisoning. Objective: The objective of this research was to assess the clinical and statistical aspects of patients having acute organophosphorus (OP) poisoning. The treatment of this poisoning and its results are also determined. Patients and Methods: This research was carried out at Jinnah Hospital, Lahore (April to November 2018). Total patients selected for this research were fifty in number. These patients were having acute organophosphorus (OP) poisoning. The age of all patients was more than 12 years. The measurement was made regarding clinical and statistical aspects, behaviours and pathway of poisoning, treatment and outcomes. Results: Total patients in this research were fifty. The male and female were 39 (78%) and 11 (22%) respectively. Mean age of the patients was (24 ± 6.17) years. OP orally was taken by 48 (965) and the number of patients exposed to it through inhalation was 2 (4%). A total of 37 (74%) patients committed suicidal attempt. Thirteen patients (26%) were presented with accidental exposure. 1.68 hours was the mean time from exposure to the presentation in the emergency department. The patients who were subjected to death due to organophosphorus (OP) poisoning were three. Conclusion: In young males, the incidence of organophosphorus (OP) poisoning is more common that is usually suicidal. Death rate can be reduced by prompt management. Keywords: Organophosphorus (OP) Pesticides, Poisoning, Oral and Management.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.